Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid syndrome

G R Hughes1

  • 1Lupus Research Unit, Rayne Institute, St. Thomas' Hospital, London, UK.

Lupus
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Antiphospholipid syndrome is a significant cause of thrombosis, stroke, and pregnancy loss. This condition, increasingly recognized across medical fields, may soon be more prevalent than Lupus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minocycline-induced arthritis.

Clinical and experimental rheumatology·1998
Same author

Does SLE flare during pregnancy?

Scandinavian journal of rheumatology. Supplement·1998
Same author

Therapeutic advances in systemic lupus erythematosus.

Current opinion in rheumatology·1998
Same author

Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.

British journal of rheumatology·1998
Same author

Lack of cross-reaction between antibodies to beta2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome.

British journal of rheumatology·1998
Same author

Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.

Arthritis and rheumatism·1998
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

Area of Science:

  • Rheumatology
  • Hematology
  • Obstetrics & Gynecology

Background:

  • Antiphospholipid syndrome (APS) is a complex autoimmune disorder.
  • Early recognition was hindered by its primary publication in rheumatology literature.
  • APS is now a globally recognized cause of significant medical complications.

Purpose of the Study:

  • To highlight the growing importance and prevalence of antiphospholipid syndrome.
  • To underscore its impact across multiple medical specialties.
  • To compare its potential prevalence with Systemic Lupus Erythematosus.

Main Methods:

  • Literature review and synthesis of existing data.
  • Analysis of reported cases and diagnostic criteria.
  • Epidemiological trend assessment.

Related Experiment Videos

Main Results:

  • Antiphospholipid syndrome is a major cause of venous and arterial thrombosis.
  • It is also linked to strokes, valvular heart disease, and recurrent pregnancy loss.
  • The syndrome's prevalence is increasing and may surpass that of Lupus.

Conclusions:

  • Antiphospholipid syndrome is a critical condition with widespread clinical implications.
  • Increased awareness and interdisciplinary collaboration are essential for diagnosis and management.
  • Further research into prevalence and management strategies is warranted.